Cas no 120073-83-8 ((4-methylfuran-2-yl)methanamine)
(4-methylfuran-2-yl)methanamine Chemical and Physical Properties
Names and Identifiers
-
- 4-methyl-2-Furanmethanamine
- (4-methylfuran-2-yl)methanamine
- EN300-378052
- 120073-83-8
- SCHEMBL9022971
- AKOS006363528
- P11789
- CS-0057623
- HMHSVQXZBMKUMA-UHFFFAOYSA-N
- PB24200
-
- Inchi: 1S/C6H9NO/c1-5-2-6(3-7)8-4-5/h2,4H,3,7H2,1H3
- InChI Key: HMHSVQXZBMKUMA-UHFFFAOYSA-N
- SMILES: O1C=C(C)C=C1CN
Computed Properties
- Exact Mass: 111.068413911g/mol
- Monoisotopic Mass: 111.068413911g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 8
- Rotatable Bond Count: 1
- Complexity: 74.9
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.2
- Topological Polar Surface Area: 39.2?2
(4-methylfuran-2-yl)methanamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M241765-50mg |
4-Methyl-2-furanmethanamine |
120073-83-8 | 50mg |
$ 930.00 | 2022-06-04 | ||
| TRC | M241765-100mg |
4-Methyl-2-furanmethanamine |
120073-83-8 | 100mg |
$ 1545.00 | 2022-06-04 | ||
| TRC | M241765-250mg |
4-Methyl-2-furanmethanamine |
120073-83-8 | 250mg |
$ 3090.00 | 2022-06-04 | ||
| Chemenu | CM390291-100mg |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95%+ | 100mg |
$718 | 2023-03-07 | |
| Chemenu | CM390291-250mg |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95%+ | 250mg |
$1077 | 2023-03-07 | |
| Chemenu | CM390291-500mg |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95%+ | 500mg |
$771 | 2022-06-14 | |
| Chemenu | CM390291-1g |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95%+ | 1g |
$964 | 2022-06-14 | |
| Enamine | EN300-378052-0.05g |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95% | 0.05g |
$229.0 | 2023-05-27 | |
| Enamine | EN300-378052-0.1g |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95% | 0.1g |
$342.0 | 2023-05-27 | |
| Enamine | EN300-378052-0.25g |
(4-methylfuran-2-yl)methanamine |
120073-83-8 | 95% | 0.25g |
$487.0 | 2023-05-27 |
(4-methylfuran-2-yl)methanamine Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
Additional information on (4-methylfuran-2-yl)methanamine
Compound CAS No. 120073-83-8: (4-Methylfuran-2-yl)methanamine
The compound with CAS No. 120073-83-8, commonly referred to as (4-methylfuran-2-yl)methanamine, is a fascinating organic molecule that has garnered significant attention in the fields of organic chemistry, pharmacology, and materials science. This compound is characterized by its unique structure, which combines a methylfuran ring with a methanamine group, making it a versatile building block for various applications.
Methylfuran derivatives have long been recognized for their stability and reactivity in chemical reactions. The presence of the methyl group at the 4-position of the furan ring introduces steric effects that can influence the molecule's reactivity and selectivity in synthetic processes. This makes (4-methylfuran-2-yl)methanamine an attractive candidate for use in asymmetric synthesis, catalysis, and drug design.
Recent studies have highlighted the potential of (4-methylfuran-2-yl)methanamine in the development of novel therapeutic agents. Researchers have explored its ability to act as a precursor for bioactive compounds, particularly in the context of enzyme inhibition and receptor modulation. For instance, investigations into its role as a ligand for G-protein coupled receptors (GPCRs) have shown promising results, suggesting its potential in treating conditions such as inflammation and neurodegenerative diseases.
In addition to its pharmacological applications, (4-methylfuran-2-yl)methanamine has also found utility in materials science. Its ability to form stable coordination complexes with transition metals has led to its use in catalytic systems for organic transformations. Recent advancements in this area have demonstrated enhanced catalytic efficiency when this compound is employed as a ligand in palladium-catalyzed cross-coupling reactions.
The synthesis of (4-methylfuran-2-yl)methanamine has been optimized through various methodologies, including organocatalytic approaches and transition metal-mediated reactions. These methods not only improve yield but also enhance the sustainability of the production process, aligning with current trends toward green chemistry.
Furthermore, computational studies have provided deeper insights into the electronic structure and reactivity of (4-methylfuran-2-yl)methanamine. Density functional theory (DFT) calculations have revealed key orbital interactions that govern its participation in nucleophilic and electrophilic reactions, offering valuable guidance for future synthetic strategies.
In conclusion, (4-methylfuran-2-yl)methanamine (CAS No. 120073-83-8) stands out as a multifaceted compound with significant potential across diverse scientific domains. Its unique chemical properties, combined with recent research advancements, underscore its importance as a valuable tool in modern chemical research and development.
120073-83-8 ((4-methylfuran-2-yl)methanamine) Related Products
- 165737-48-4(2-Benzofuranmethanamine,7-methyl-)
- 388072-09-1(2-Aminomethyl-3-methylfuran)
- 769906-98-1(5-Aminomethyl-furan-3-carbonitrile)
- 306934-85-0((2,5-dimethylfuran-3-yl)methanamine)
- 3710-43-8(2,4-dimethylfuran)
- 1219799-26-4(Furfuryl-d5-amine)
- 114582-77-3(3-Furanmethanol,5-(aminomethyl)-)
- 79127-87-0(Furanmethanamine)
- 232280-80-7(3-Furancarbonitrile,5-(aminomethyl)-, hydrochloride (1:1))
- 916766-86-4(methyl(3-methylfuran-2-yl)methylamine)